|Bid||68.23 x 1000|
|Ask||68.44 x 800|
|Day's Range||64.18 - 68.48|
|52 Week Range||26.57 - 69.00|
|Beta (5Y Monthly)||0.91|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 02, 2021 - Aug 06, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||69.00|
Investors continue to be optimistic about Henry Schein (HSIC) on its extensive global foothold and bullish 2021 earnings guidance.
According to Abbott (ABT), significant reductions in the number of COVID-19 cases in the United States and other major developed countries to hamper demand for COVID-19 testing in 2021.
GOLETA, Calif., Jun 21, 2021--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Jason Somer as Inogen’s Executive Vice President and General Counsel and Secretary, effective July 12, 2021.